title: Systolic blood pressure and mortality in patients on hemodialysis.
abstract: Hypertension is extremely common in patients with end-stage renal disease who are receiving hemodialysis, and cardiovascular disease remains the leading cause of death in these patients. However, optimal blood pressure management strategies in this high-risk population are still controversial. This review first discusses the complex association of systolic blood pressure with clinical outcomes in patients on hemodialysis, with a focus on several recent studies. Next, it updates the reader on issues related to optimal timing and methods of blood pressure measurement, appropriate blood pressure targets, and pharmacologic and nonpharmacologic hypertension treatment strategies for patients on hemodialysis.
authors.affiliation: Palo Alto, CA 94304, USA. tichang@stanford.edu
authors.forename: Tara I
authors.initials: TI
authors.lastname: Chang
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure; D001795:Blood Pressure Determination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000401:mortality*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000401:mortality* / Q000628:therapy; D006435:Renal Dialysis / Q000401:mortality* / Q000706:statistics & numerical data; D017673:Sodium Chloride, Dietary / Q000008:administration & dosage; D014481:United States
chemical_list: D000959:Antihypertensive Agents; D017673:Sodium Chloride, Dietary